Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

STREPSILS CHESTY COUGH LOZENGE

Approval Number

SIN11716P

Drug Name

STREPSILS CHESTY COUGH LOZENGE

Product Name

STREPSILS CHESTY COUGH LOZENGE

Approval Date

November 15, 2001

Registrant

RECKITT BENCKISER (SINGAPORE) PTE LTD

Licence Holder

RECKITT BENCKISER (SINGAPORE) PTE LTD

Regulatory Information

Registrant

RECKITT BENCKISER (SINGAPORE) PTE LTD

Licence Holder

RECKITT BENCKISER (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

General Sale List

Formulation Information

Dosage Form

LOZENGE

Route of Administration

ORAL

Medical Information

ATC Code

R05CB06

ATC Item Name

ambroxol

Manufacturer Information

Pharmaceutical Manufacturer

RECKITT BENCKISER (SINGAPORE) PTE LTD

Manufacturers

RECKITT BENCKISER HEALTHCARE MANUFACTURING (THAILAND) LTD

Active Ingredients

Ingredient Name

AMBROXOL HCl

Strength

15 mg

Drug MonographAmbroxol

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

STREPSILS CHESTY COUGH LOZENGE - HSA Approval | MedPath